The Use of Probiotics in Gastrointestinal Disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Probiotics are living microorganisms that can affect the host in a beneficial manner. Prebiotics are nondigestible food ingredients that stimulate the growth and activity of probiotic bacteria already established in the colon. Efficacy of probiotic compounds has been shown in a wide range of gastrointestinal diseases.Lactobacillus GG alone, or the combination of Bifidobacterium bifidum and Streptococcus thermophilus,is effective in the treatment of Clostridium difficile,as well as in preventing the frequency and severity of infectious acute diarrhea in children. Prevention of antibiotic-induced diarrhea with the concomitant administration of either Lactobacillus GG or Saccharomyces boulardii has been demonstrated. The most successful studies involve the use of Lactobacillus GG at a dose of 1×10 10 viable organisms per day and the yeast boulardii at a dose of 1 g/day. A probiotic preparation (VSL#3 - 6 g/day) that uses a combination of three species of Bifidobacterium, four strains of Lactobacillus and one strain of Streptocccus has shown promise in maintaining remission in ulcerative colitis and pouchitis, as well as in preventing the postoperative recurrence of Crohn's disease. The mechanism of action of probiotics may include receptor competition, effects on mucin secretion or probiotic immunomodulation of gut-associated lymphoid tissue. Oral administration of probiotic compounds has been demonstrated to be well tolerated and safe. However, while probiotics have the potential to improve human health and to prevent and treat some diseases, major improvements are needed in labelling and quality assurance procedures for probiotic compounds. In addition, well planned and controlled clinical studies are necessary to delineate fully the potential for probiotic compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The indigenous gastrointestinal microflora
Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · cited 1×
“At least three major bacterial habitats have been described: the lumen of the gastrointestinal tract, the mucus gel that overlies the epithelium and the adherence of bacteria to receptors on mucosal epithelial cells (6).”
BackgroundLactobacillemia in liver transplant patients
Patel, R., Cockerill, F. R., Porayko, M. K., Osmon, D. R., Ilstrup, D. M., & Keating, M. R. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.207 · Cited by 100 · cited 1×
“These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
BackgroundLactobacillemia in three patients with AIDS
Horwitch, C. A., Furseth, H. A., Larson, A. M., Jones, T. L., Olliffe, J. F., & Spach, D. H. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1460 · Cited by 78 · cited 1×
“These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
BackgroundLactobacillus Species as Opportunistic Pathogens in Immunocompromised Patients
Schlegel, L., Lemerle, S., & Geslin, P. (1998) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050216 · Cited by 69 · cited 1×
“These infections have occurred in immunocompromised patients with aplasia (40), organ transplantation (41) and human immunodeficiency virus infection (42,43).”
Background
Cited by
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
New Scientific Paradigms for Probiotics and Prebiotics
Reid, G., Sanders, M. E., Gaskins, H. R., Gibson, G. R., Mercenier, A., Rastall, R., Roberfroid, M., Rowland, I., Cherbut, C., & Klaenhammer, T. R. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200308000-00004 · Cited by 495
Lavasani, S., Dzhambazov, B., Nouri, M., Fåk, F., Buske, S., Molin, G., Thorlacius, H., Alenfall, J., Jeppsson, B., & Weström, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009009 · Cited by 449
Functional modulation of enterocytes by gram-positive and gram-negative microorganisms
Otte, J.-M., & Podolsky, D. K. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00341.2003 · Cited by 403
Microbial translocation, immune activation, and HIV disease
Klatt, N. R., Funderburg, N. T., & Brenchley, J. M. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2012.09.001 · Cited by 390
Rebuilding the Gut Microbiota Ecosystem
Gagliardi, A., Totino, V., Cacciotti, F., Iebba, V., Neroni, B., Bonfiglio, G., Trancassini, M., Passariello, C., Pantanella, F., & Schippa, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081679 · Cited by 340
Ma, D., Forsythe, P., & Bienenstock, J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5308-5314.2004 · Cited by 289
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Guo, Q., Goldenberg, J. Z., Humphrey, C., El Dib, R., & Johnston, B. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub5 · Cited by 275
“More than 400 species of bacteria inhabit the human gut, and a balance of these micro-organisms is important for normal gastrointestinal function (Madsen 2001).”
BackgroundThe Role of Probiotics and Prebiotics in Inducing Gut Immunity
Vieira, A. T., Teixeira, M. M., & Martins, F. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00445 · Cited by 273
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis
Kühbacher, T., Ott, S. J., Helwig, U., Mimura, T., Rizzello, F., Kleessen, B., Gionchetti, P., Blaut, M., Campieri, M., Fölsch, U. R., et al. (2006) · Gut · doi:10.1136/gut.2005.078303 · Cited by 257
Dieleman, L. A., Goerres, M. S., Arends, A., Sprengers, D., Torrice, C., Hoentjen, F., Grenther, W. B., & Sartor, R. B. (2003) · Gut · doi:10.1136/gut.52.3.370 · Cited by 232
Boudeau, J., Glasser, A. ‐., Julien, S., Colombel, J. ‐., & Darfeuille‐Michaud, A. (2003) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2003.01638.x · Cited by 206
Lactobacillus GG Bacteria Ameliorate Arthritis in Lewis Rats
Baharav, E., Weinberger, A., Mor, F., & Halpern, M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.8.1964 · Cited by 144
Corridoni, D., Pastorelli, L., Mattioli, B., Locovei, S., Ishikawa, D., Arseneau, K. O., Chieppa, M., Cominelli, F., & Pizarro, T. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042067 · Cited by 118
“VSL#3 is a mixture of Streptococcus thermophilus, three strains of Bifidobacterium and four strains of Lactobacillus, and has been proven to be efficacious in treating established colitis in IL-10 knockout (KO) mice [20–22], and to induce remission in patients with UC [23–27].”
BackgroundLee, J., Yang, W., Hostetler, A., Schultz, N., Suckow, M. A., Stewart, K. L., Kim, D. D., & Kim, H. S. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0686-7 · Cited by 107
Probiotics: Immunomodulation and Evaluation of Safety and Efficacy
Ezendam, J., & Loveren, H. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00168.x · Cited by 103
Kefir Improves the Efficacy and Tolerability of Triple Therapy in Eradicating Helicobacter pylori
Bekar, O., Yilmaz, Y., & Gulten, M. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.0099 · Cited by 84
“7,8 Probiotics are live microorganisms that when administered in adequate amounts confer a health benefit on the host and include Streptococcus thermophilus , Enterococcus species, Saccharomyces species, and various species of lactobacilli and bifidobacteria.”
Sentongo, T. A., Cohran, V., Korff, S., Sullivan, C., Iyer, K., & Zheng, X. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000304452.92175.f5 · Cited by 51
“Probiotics are nutritional supplements that contain cultures of one or more nonpathogenic strains of bacteria or fungal organisms, which, when ingested in adequate amounts, exert a health benefit to the host (14).”
BackgroundThe Role of Fatty Acid Metabolites in Vaginal Health and Disease: Application to Candidiasis
Baldewijns, S., Sillen, M., Palmans, I., Vandecruys, P., Van Dijck, P., & Demuyser, L. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.705779 · Cited by 44
“This yeast is currently being used in the treatment of chronic and acute gastrointestinal diseases like inflammatory bowel disease, bacterial and rotaviral diarrhea (Madsen, 2001; Kelesidis and Pothoulakis, 2012).”
Method
Metadata
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.